These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29917186)

  • 1. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
    Zhang HH; Li AH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
    Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
    Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
    Deng J; Liang Y; Liu C; He S; Wang S
    Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
    Zhao X; Cheng Z; Wang J
    Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer.
    Zhu LF; Song LD; Xu Q; Zhan JF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5122-5132. PubMed ID: 31298365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer.
    Liu W; Li Y; Zhang Y; Shen X; Su Z; Chen L; Cai W; Wang F; Ju S
    Pathol Res Pract; 2020 Jan; 216(1):152757. PubMed ID: 31785996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
    Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
    Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
    [No Abstract]   [Full Text] [Related]  

  • 11. FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma.
    Quan LJ; Wang WJ
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31076545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
    Liu CN; Zhang HY; Liu CL; Wang CC
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of long noncoding RNA HMMR-AS1 in epithelial ovarian cancer: an independent prognostic factor.
    Chu ZP; Dai J; Jia LG; Li J; Zhang Y; Zhang ZY; Yan P
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8145-8150. PubMed ID: 30556852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA FEZF1-AS1 in human cancers.
    Zhou Y; Xu S; Xia H; Gao Z; Huang R; Tang E; Jiang X
    Clin Chim Acta; 2019 Oct; 497():20-26. PubMed ID: 31276636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
    Li AH; Zhang HH
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and diagnostic significance of long non-coding RNA AGAP2-AS1 levels in patients with non-small cell lung cancer.
    Fan KJ; Liu Y; Yang B; Tian XD; Li CR; Wang B
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2392-2396. PubMed ID: 28617550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of BOK-AS1, FAM215A and FEZF1-AS1 lncRNAs and their potency as moderate diagnostic biomarkers in gastric cancer.
    Moazzen H; Rajabi A; Safaralizadeh R
    Pathol Res Pract; 2023 Aug; 248():154639. PubMed ID: 37364417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
    Tan J; Yang L
    Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA ZEB1-AS1 expression predicts progression and poor prognosis of colorectal cancer.
    Fu J; Cui Y
    Int J Biol Markers; 2017 Oct; 32(4):e428-e433. PubMed ID: 28967064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.